The Effect of Covalently Immobilized FGF-2 on Biphasic Calcium Phosphate Bone Substitute on Enhanced Biological Compatibility and Activity

Figure 5

(a) Images of FDA–stained cells and (b) MTT assay results from hMSCs. Con: Uncoated Biphasic Calcium Phosphate (control). 20D: Cells cultured on BCP dosed with 20 ng FGF-2. 10C, 50C, 100C, 200C, and 400C: 10, 50, 100, 200, and 400 ng FGF-2 coated BCP. Different alphabetical letter shows statistical differences.

(a)

(b)